ClinicalTrials.gg
Status unknownNCT04809675Updated Mar 22, 2021

Effectiveness of Two Oral Appliances for Managing Oral Self-biting Injuries in Patients With ALS

An interventional study of Hard occlusal splint and Flexible customized mouthguard in Satisfaction, sponsored by University of Barcelona. Status unknown at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-03-22.

Sponsored by University of Barcelona · Not applicable, Interventional, and Supportive care

How we know

The sponsor has not verified this record recently (last verified Mar 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Nov 2019, registered Apr 2020).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 24 studies in Personal Satisfaction with a site in Spain — 5 open to participants now, 5 under way, none of them phase 3. Personal Satisfaction · Spain.

Planned enrollment
16th of 19
31 · median 96
Started
2019
with 3 others
No phase
14 of 24
3 open now
Registered
15th of 24
by date
Lead sponsor
4 of 24
University of Barcelona

Among the 24 studies in Personal Satisfaction with a site in Spain, this one is the 16th largest by planned enrollment of the 19 interventional ones that give a count, is one of 4 that started in 2019, is one of 14 with no phase, and was the 15th registered.

Personal Satisfaction

543 studies on the registry are indexed under Personal Satisfaction; 91 are open to participants now.

Browse Personal Satisfaction studies →

Open to participants now

5 of the 24 studies in Personal Satisfaction with a site in Spain are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 38 Personal Satisfaction studies recruiting now, 18 (47%) set no upper age limit and 15 (39%) stop at 75 or younger; 8 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Personal Satisfaction with a site in Spain, or all of them as a file.
02

Study summary

This study assesses to determine the most effective type of device on the degree of satisfaction of patients with amyotrophic lateral sclerosis for managing oral self-biting injuries. Thirty-one patients with amyotrophic lateral sclerosis will wear two devices, a hard occlusal splint (HOS) and a flexible customized mouthguard (FCM), for two weeks each one. The sequence will be randomized to obtain one-half of the participants starting the first week wearing the HOS, and the other half wearing the FCM. The participants will rate the degree of satisfaction with the device and the degree of improvement or worsening of oral self-biting injuries in a 10-point scale. They will also rate the degree of change in their quality of life because of changes in their oral self-biting injuries. Finally they will rate the compliance and report the adverse effects.

Read the detailed description

This crossover intervention study aims to assess the most effective type of device on the degree of satisfaction of patients with amyotrophic lateral sclerosis for managing oral self-biting injuries. Thirty-one patients with amyotrophic lateral sclerosis diagnosed in the ALS Functional Unit at Bellvitge University Hospital will participate in this randomized crossover trial. Two devices will be prepared for each patient, a hard occlusal splint (HOS) and a flexible customized mouthguard (FCM). They will wear one type of device for the first two weeks, followed by a week off, and the other type of device for the fourth and fifth week. The sequence will be randomized to obtain one-half of the participants starting the first week wearing the HOS, and the other half wearing the FCM. The participants will rate the degree of satisfaction with the device in a 10-point scale, considering 0 extremely dissatisfied and 10 completely satisfied, and the degree of improvement or worsening of oral self-biting injuries, considering 0 an extreme worsening and 10 completely improved. They will also rate the degree of change in their quality of life (nothing, a bit, quite, a lot) because of changes in their oral self-biting injuries. Finally they will rate the compliance as the percentage of time the device was used with respect to the recommended time and report the adverse effects (excessive salivation, dry mouth, tooth pain, mucosal irritation, temporomandibular joint (TMJ) pain, TMJ sounds, bite change, other).

03

Conditions studied

  • Satisfaction

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with amyotrophic lateral sclerosis diagnosed in the ALS Functional Unit at Bellvitge University Hospital.

Exclusion criteria

Exclusion Criteria:

  • Patients who cannot be treated due to the advanced evolution of their disease.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
31 participants (estimated)

Study arms

  • Active comparator
    HOS-HOS-FCM-FCM sequence

    Use of a hard occlusal splint (HOS) for the first two weeks, followed by a week off, and a flexible customized mouthguard (FCM) for the fourth and fifth week.

    Device: Hard occlusal splint · Device: Flexible customized mouthguard

  • Active comparator
    FCM-FCM-HOS-HOS sequence

    Use of a flexible customized mouthguard (FCM) for the first two weeks, followed by a week off, and a hard occlusal splint (HOS) for the fourth and fifth week.

    Device: Hard occlusal splint · Device: Flexible customized mouthguard

Interventions

  • DeviceHard occlusal splint

    Use of a hard occlusal splint at times they considered helpful.

  • DeviceFlexible customized mouthguard

    Use of a flexible customized mouthguard at times they considered helpful.

06

What researchers measure

Primary outcomes

  1. Degree of satisfaction using a questionnarie

    Participant satisfaction will be assessed by asking the question "How satisfied are you with the device?" using a 0-10 point scale (considering 0= extremely dissatisfied and 10 = completely satisfied)

    Time frame: 1-2 weeks

Secondary outcomes

  1. Degree of improvement or worsening of oral self-biting injuries using a questionnarie

    The degree of improvement or worsening of oral self-biting injuries while using the device will be assessed by asking the question "How much do you think wearing the device improves the oral self-biting injuries?" using a 0-10 point scale (considering 0= extreme worsening to 10= completely improved).

    Time frame: 1-2 weeks

  2. Degree of change in their quality of life using a questionnaire

    The degree of change in their quality of life while using the device because of changes in their oral self-biting injuries will be assessed by asking the question "How much do you think wearing the device improves your quality of life?" using a 4-point scale (considering 0 = nothing, 1 = a bit, 2 = quite, 4 = a lot).

    Time frame: 1-2 weeks

  3. Compliance

    Participants compliance using the device will be assessed as the percentage of time the device was used with respect to the recommended time.

    Time frame: 1-2 weeks

  4. Adverse effects

    The adverse effects related to use of the device will be recorded (excessive salivation, dry mouth, tooth pain, mucosal irritation, temporomandibular joint (TMJ) pain, TMJ sounds, bite change, other).

    Time frame: 1-2 weeks

  5. Willingness to pay

    Participants willingness to pay will be assessed by asking the question "What is the maximum you would pay for the device?"

    Time frame: 1-2 weeks

07

Study locations

1 of 1 sites recruiting
  • Nina Riera-Punet
    Barcelona, L'Hospitalet De Llobregat 08907, Spain
    Recruiting
08

References and documents

Publications

  • Riera-Punet N, Martinez-Gomis J, Paipa A, Povedano M, Peraire M. Alterations in the Masticatory System in Patients with Amyotrophic Lateral Sclerosis. J Oral Facial Pain Headache. 2018 Winter;32(1):84-90. doi: 10.11607/ofph.1882. Epub 2017 Dec 15. PubMed 29244892 ↗
  • Riera-Punet N, Martinez-Gomis J, Willaert E, Povedano M, Peraire M. Functional limitation of the masticatory system in patients with bulbar involvement in amyotrophic lateral sclerosis. J Oral Rehabil. 2018 Mar;45(3):204-210. doi: 10.1111/joor.12597. Epub 2017 Dec 30. PubMed 29240971 ↗
  • Riera-Punet N, Martinez-Gomis J, Zamora-Olave C, Willaert E, Peraire M. Satisfaction of patients with amyotrophic lateral sclerosis with an oral appliance for managing oral self-biting injuries and alterations in their masticatory system: A case-series study. J Prosthet Dent. 2019 Apr;121(4):631-636. doi: 10.1016/j.prosdent.2018.06.010. Epub 2018 Nov 30. PubMed 30503152 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2019 (actual). Primary completion is estimated for Sep 2021, 22 months after the start.

Of 250 non-industry interventional studies with no phase under Personal Satisfaction, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's planned 22 months is above that.

Counting every sponsor, half of 257 studies reached it within 9 months; a quarter within 3 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2020
First posted
Mar 22, 2021
StartActual
Nov 29, 2019
Primary completionEst.
Sep 2021
CompletionEst.
Dec 2021
Last update
Mar 22, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 22, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04809675
Responsible party
Nina Riera-Punet (Associate professor DDS PhD, University of Barcelona) — Principal investigator
First posted
Mar 22, 2021
Start date
Nov 29, 2019
Primary completion
Sep 2021 (estimated)
Completion
Dec 2021 (estimated)
Last update
Mar 22, 2021

Study contacts

Nina Riera-Punet, DDS PhD
Contact
ninariera@ub.edu
934035555 ext. +34

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion